
Pharmacally
Deucrictibant
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Deucrictibant
Clinical TrialsPharvaris Reports Positive Results for Oral Deucrictibant in HAE TrialPharvaris has announced the publication of its Phase 3 RAPIDe-3 trial results in The Lancet.Fact-Checked
Clinical TrialsFDA Accepts Pharvaris’ Deucrictibant NDA for HAEThe FDA’s acceptance of Pharvaris’s NDA for deucrictibant IR supported by pivotal Phase 3 data from RAPIDe-3 (NCT06343779) showing rapid, sustained HAE attack relief sets a PDUFA action…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.